HUE040914T4 - Immunogén készítmény - Google Patents
Immunogén készítményInfo
- Publication number
- HUE040914T4 HUE040914T4 HUE13743463A HUE13743463A HUE040914T4 HU E040914 T4 HUE040914 T4 HU E040914T4 HU E13743463 A HUE13743463 A HU E13743463A HU E13743463 A HUE13743463 A HU E13743463A HU E040914 T4 HUE040914 T4 HU E040914T4
- Authority
- HU
- Hungary
- Prior art keywords
- immunogenic composition
- immunogenic
- composition
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN281MU2012 | 2012-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE040914T4 true HUE040914T4 (hu) | 2019-05-28 |
Family
ID=54259032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13743463A HUE040914T4 (hu) | 2012-01-30 | 2013-01-29 | Immunogén készítmény |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9198977B2 (https=) |
| EP (1) | EP2809349B1 (https=) |
| JP (1) | JP6042455B2 (https=) |
| KR (1) | KR101897317B1 (https=) |
| CN (1) | CN104302315B (https=) |
| BR (1) | BR112014018815B1 (https=) |
| CA (1) | CA2863178C (https=) |
| DK (1) | DK2809349T3 (https=) |
| ES (1) | ES2707294T3 (https=) |
| HU (1) | HUE040914T4 (https=) |
| MX (1) | MX354103B (https=) |
| PT (1) | PT2809349T (https=) |
| RU (1) | RU2634405C2 (https=) |
| SG (1) | SG11201404447WA (https=) |
| SI (1) | SI2809349T1 (https=) |
| TR (1) | TR201900778T4 (https=) |
| WO (1) | WO2013114268A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8398983B2 (en) | 2005-06-27 | 2013-03-19 | Glaxosmithkline Biologicals, S.A. | Immunogenic composition |
| RU2627156C2 (ru) * | 2012-11-21 | 2017-08-03 | Серум Инститьют Оф Индия Прайват Лтд. | Высокоэффективный способ получения бактериального полисахарида, получение конъюгата на его основе и иммуногенная композиция |
| EP3035957B1 (en) | 2013-08-24 | 2019-11-20 | Bharat Biotech International Limited | A bacterial vaccine and methods for manufacture thereof |
| EP2921856B1 (en) | 2014-03-18 | 2016-09-14 | Serum Institute Of India Private Limited | A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines |
| PE20180460A1 (es) | 2015-06-08 | 2018-03-06 | Serum Inst Of India Private Ltd | Metodos para mejorar la adsorcion de conjugados de polisacarido-proteina y una formulacion de vacuna multivalente obtenida con los mismos |
| WO2017006349A1 (en) * | 2015-07-04 | 2017-01-12 | Bharat Biotech International Limited | Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides |
| KR102428253B1 (ko) * | 2016-03-15 | 2022-08-02 | 엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드 | 신규한 다당류-단백질 접합체 및 이의 제조방법 |
| CN106110316A (zh) * | 2016-06-27 | 2016-11-16 | 北京智飞绿竹生物制药有限公司 | 一种肺炎球菌结合物组合疫苗的制备方法 |
| KR102906912B1 (ko) * | 2016-09-02 | 2026-01-05 | 사노피 파스퇴르 인크 | 네이세리아 메닌기티디스 백신 |
| CN106397537B (zh) * | 2016-10-13 | 2020-01-07 | 李红臣 | 一种高效快速的多糖蛋白结合疫苗纯化分析方法 |
| JP7319929B2 (ja) * | 2017-05-05 | 2023-08-02 | セラム インスティテュート オブ インディア プライベート リミティド | 細菌性莢膜多糖ベース調製物からの不純物の除去方法 |
| JP2020525495A (ja) * | 2017-06-27 | 2020-08-27 | エムエスディー ウェルカム トラスト ヒルマン ラボラトリーズ プライベート リミテッドＭｓｄ Ｗｅｌｌｃｏｍｅ Ｔｒｕｓｔ Ｈｉｌｌｅｍａｎ Ｌａｂｏｒａｔｏｒｉｅｓ Ｐｖｔ．Ｌｔｄ． | 新規の多価多糖類・タンパク質のコンジュゲートワクチン組成物及びその製剤 |
| WO2019145981A1 (en) * | 2018-01-29 | 2019-08-01 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Novel meningococcal vaccine composition and process thereof |
| WO2019198096A1 (en) * | 2018-04-11 | 2019-10-17 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Tetravalent meningococcal vaccine composition and process to prepare thereof |
| JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
| EP4034157A1 (en) | 2019-09-27 | 2022-08-03 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| WO2022035816A1 (en) | 2020-08-10 | 2022-02-17 | Inventprise, Llc | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f |
| CN118078981A (zh) * | 2024-04-26 | 2024-05-28 | 成都康华生物制品股份有限公司 | 一种基于双蛋白载体的五价脑膜炎球菌多糖结合疫苗的制备方法及其产品 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| HU227893B1 (en) * | 2000-06-29 | 2012-05-29 | Glaxosmithkline Biolog Sa | Vaccine compositions |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0130215D0 (en) * | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
| CN103357002A (zh) * | 2003-10-02 | 2013-10-23 | 诺华疫苗和诊断有限公司 | 多种脑膜炎球菌血清群的液体疫苗 |
| GB0513069D0 (en) * | 2005-06-27 | 2005-08-03 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US8398983B2 (en) * | 2005-06-27 | 2013-03-19 | Glaxosmithkline Biologicals, S.A. | Immunogenic composition |
| NZ598367A (en) * | 2005-09-01 | 2013-10-25 | Novartis Vaccines & Diagnostic | Multiple vaccination including serogroup C meningococcus |
| PL1973564T3 (pl) * | 2005-12-22 | 2017-04-28 | Glaxosmithkline Biologicals S.A. | Szczepionki zawierające koniugaty polisacharydu otoczkowego streptococcus pneumoniae |
| GB0703369D0 (en) * | 2007-02-21 | 2007-03-28 | Health Prot Agency | Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines |
| MX2012006961A (es) * | 2009-12-17 | 2012-10-03 | Fina Biosolutions Llc | Reactivos quimicos para la activacion de polisacaridos en la preparacion de vacunas conjugadas. |
| WO2013174832A1 (en) * | 2012-05-22 | 2013-11-28 | Novartis Ag | Meningococcus serogroup x conjugate |
-
2013
- 2013-01-29 DK DK13743463.5T patent/DK2809349T3/da active
- 2013-01-29 WO PCT/IB2013/050739 patent/WO2013114268A1/en not_active Ceased
- 2013-01-29 MX MX2014009250A patent/MX354103B/es active IP Right Grant
- 2013-01-29 PT PT13743463T patent/PT2809349T/pt unknown
- 2013-01-29 RU RU2014134288A patent/RU2634405C2/ru active
- 2013-01-29 CN CN201380017781.9A patent/CN104302315B/zh active Active
- 2013-01-29 TR TR2019/00778T patent/TR201900778T4/tr unknown
- 2013-01-29 ES ES13743463T patent/ES2707294T3/es active Active
- 2013-01-29 US US14/375,385 patent/US9198977B2/en active Active
- 2013-01-29 EP EP13743463.5A patent/EP2809349B1/en active Active
- 2013-01-29 HU HUE13743463A patent/HUE040914T4/hu unknown
- 2013-01-29 CA CA2863178A patent/CA2863178C/en active Active
- 2013-01-29 BR BR112014018815-7A patent/BR112014018815B1/pt active IP Right Grant
- 2013-01-29 SG SG11201404447WA patent/SG11201404447WA/en unknown
- 2013-01-29 SI SI201331329T patent/SI2809349T1/sl unknown
- 2013-01-29 KR KR1020147024348A patent/KR101897317B1/ko active Active
- 2013-01-29 JP JP2014555364A patent/JP6042455B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX354103B (es) | 2018-02-13 |
| KR20140123553A (ko) | 2014-10-22 |
| SG11201404447WA (en) | 2014-08-28 |
| EP2809349B1 (en) | 2018-12-19 |
| US9198977B2 (en) | 2015-12-01 |
| CN104302315B (zh) | 2018-02-06 |
| PT2809349T (pt) | 2019-02-01 |
| CA2863178A1 (en) | 2013-08-08 |
| EP2809349A1 (en) | 2014-12-10 |
| CA2863178C (en) | 2021-04-06 |
| SI2809349T1 (sl) | 2019-03-29 |
| JP2015509111A (ja) | 2015-03-26 |
| BR112014018815A2 (https=) | 2017-06-20 |
| BR112014018815A8 (pt) | 2017-07-11 |
| WO2013114268A1 (en) | 2013-08-08 |
| RU2634405C2 (ru) | 2017-10-26 |
| JP6042455B2 (ja) | 2016-12-14 |
| US20140377302A1 (en) | 2014-12-25 |
| DK2809349T3 (da) | 2019-02-18 |
| KR101897317B1 (ko) | 2018-09-11 |
| RU2014134288A (ru) | 2016-03-20 |
| EP2809349A4 (en) | 2015-08-26 |
| TR201900778T4 (tr) | 2019-02-21 |
| BR112014018815B1 (pt) | 2022-07-12 |
| ES2707294T3 (es) | 2019-04-03 |
| MX2014009250A (es) | 2015-03-19 |
| CN104302315A (zh) | 2015-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201503927B (en) | Immunogenic composition | |
| SG11201404447WA (en) | Immunogenic composition | |
| PL2647387T3 (pl) | Kompozycja szczepionki | |
| SG11201500412TA (en) | Vaccine compositions | |
| IL238079A0 (en) | Immunogenic preparation | |
| GB201223342D0 (en) | Immunogenic composition | |
| LT2714911T (lt) | Imunogeninė kompozicija | |
| GB201200707D0 (en) | Composition | |
| SG11201500979RA (en) | Immunogenic composition | |
| EP2878295A4 (en) | COMPOSITION | |
| GB201218660D0 (en) | Immunogenic composition | |
| GB201206035D0 (en) | Composition | |
| EP2910537A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| GB201209597D0 (en) | Composition | |
| GB201208133D0 (en) | Composition | |
| GB201204968D0 (en) | Immunogenic composition | |
| GB201204851D0 (en) | Immunogenic composition | |
| GB201211154D0 (en) | Composition | |
| GB201210301D0 (en) | Composition | |
| GB201209097D0 (en) | Composition | |
| GB201208992D0 (en) | Composition | |
| GB201205861D0 (en) | Composition | |
| GB201202695D0 (en) | Composition |